Concepedia

Colleen Pineda

CP

Statistics

Publications

6

Citations

813

H-Index

6

Active since

2011

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

University of North Carolina at Chapel Hill

The Ohio State University

Colleen Pineda is an author at Alexion Pharmaceuticals (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

2011–2020

6

Publications

6

Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

Zubair Shah, Thomas Kampfrath, Jeffrey A. Deiuliis et al. · Circulation · 2011 · 375 citations · Full text

, , +17

Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways

Zubair Shah, Colleen Pineda, Thomas Kampfrath et al. · Vascular Pharmacology · 2011 · 149 citations · Full text

, , +8

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

Mamatha Pasnoor, Jianghua He, Ted M. Burns et al. · Neurology · 2016 · 131 citations · Full text

, , +14

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

1–5 of 6